Correlation Between Enzon Pharmaceuticals and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Enzon Pharmaceuticals and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzon Pharmaceuticals and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzon Pharmaceuticals and Novo Nordisk AS, you can compare the effects of market volatilities on Enzon Pharmaceuticals and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzon Pharmaceuticals with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzon Pharmaceuticals and Novo Nordisk.
Diversification Opportunities for Enzon Pharmaceuticals and Novo Nordisk
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Enzon and Novo is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Enzon Pharmaceuticals and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Enzon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzon Pharmaceuticals are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Enzon Pharmaceuticals i.e., Enzon Pharmaceuticals and Novo Nordisk go up and down completely randomly.
Pair Corralation between Enzon Pharmaceuticals and Novo Nordisk
Given the investment horizon of 90 days Enzon Pharmaceuticals is expected to under-perform the Novo Nordisk. In addition to that, Enzon Pharmaceuticals is 2.86 times more volatile than Novo Nordisk AS. It trades about -0.01 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.05 per unit of volatility. If you would invest 6,793 in Novo Nordisk AS on September 1, 2024 and sell it today you would earn a total of 3,890 from holding Novo Nordisk AS or generate 57.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 25.05% |
| Values | Daily Returns |
Enzon Pharmaceuticals vs. Novo Nordisk AS
Performance |
| Timeline |
| Enzon Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Novo Nordisk AS |
Enzon Pharmaceuticals and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enzon Pharmaceuticals and Novo Nordisk
The main advantage of trading using opposite Enzon Pharmaceuticals and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzon Pharmaceuticals position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Enzon Pharmaceuticals vs. Pmv Pharmaceuticals | Enzon Pharmaceuticals vs. NewAmsterdam Pharma | Enzon Pharmaceuticals vs. Tempest Therapeutics | Enzon Pharmaceuticals vs. IO Biotech |
| Novo Nordisk vs. Rigel Pharmaceuticals | Novo Nordisk vs. Geron | Novo Nordisk vs. Verastem | Novo Nordisk vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |